It's very difficult to think that the FDA and everyone else would risk very young children in a trial if they weren't confident that there was a benefit to be had and that it was safe to do so.
Does anyone know the number of people who continued into the Lilac trial from Lavender? The best test would be if a large number continued, as it would indicate a benefit.
- Forums
- ASX - By Stock
- NEU
- Ann: Share Purchase Plan Offer Booklet
NEU
neuren pharmaceuticals limited
Add to My Watchlist
6.69%
!
$14.20

Ann: Share Purchase Plan Offer Booklet, page-19
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$14.20 |
Change
0.890(6.69%) |
Mkt cap ! $1.761B |
Open | High | Low | Value | Volume |
$13.50 | $14.26 | $12.96 | $9.111M | 655.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2000 | $14.17 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.23 | 3278 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2000 | 14.170 |
2 | 1626 | 14.160 |
1 | 1000 | 14.100 |
2 | 2963 | 14.030 |
3 | 2000 | 14.000 |
Price($) | Vol. | No. |
---|---|---|
14.230 | 3278 | 1 |
14.250 | 2027 | 3 |
14.260 | 2920 | 1 |
14.270 | 1191 | 1 |
14.300 | 1163 | 2 |
Last trade - 16.15pm 27/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online